跳至主要内容
临床试验/NCT04256876
NCT04256876终止不适用

A Randomized-controlled Trial Comparing Transcutaneous Tibial Nerve Stimulation (TTNS) Versus Sham Therapy on Short Term Continence Outcomes in Children With the Idiopathic Overactive Bladder Syndrome: the TaPaS Trial Part I

University Hospital, Ghent1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2018年11月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
6
试验地点
1
主要终点
Mean voided volume per void

研究概览

简要总结

Part I of the TaPaS trial forms part of a twofold clinical RCT:

Part 1) A prospective RCT comparing the efficacy of transcutaneous tibial nerve stimulation (TTNS) with TTNS sham therapy for children with idiopathic overactive bladder on clinical and patient reported outcomes (PROMS).

Part 2) A prospective RCT comparing TTNS versus Percutaneous tibial nerve stimulation (PTNS) on clinical outcomes and PROMS.

详细描述

Non invasive neuromodulation therapy for children with the overactive bladder syndrome is a highly under investigated topic in medical literature.

Only 2 studies ( Patidar et al. and Boudaouid et al.) investigated the use of tibial nerve stimulation with adhesive electrodes.

  1. In the first trial the superiority of TTNS vs.Sham therapy for the therapeutic management of children with OAB naive to any pharmacological treatment will be examined.

Clinical outcomes will be assessed by the use of daytime and nighttime bladder diaries.

Assessment of outcomes at baseline, after 6 weeks and 12 weeks of treatment, and investigation of mean time to partial or complete relapse following 6 weeks observation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

盲法说明

Participants are blinded for the given treatment ( Active TTNS vs. Sham TTNS) by the care provider ( Physiotherapist).

The outcomes assessor (the pediatric urologist) isn't aware of the treatment neither.

入排标准

年龄范围
5 Years 至 12 Years(Child)
性别
All
接受健康志愿者
否

入选标准

  • •Children between 5 and 12 years old, clinically diagnosed with the idiopathic overactive bladder syndrome with urinary incontinence (daytime and/or nighttime)
  • •Untreated, except from urotherapy.

排除标准

  • •Enuresis nocturna due to nocturnal polyuria
  • •Dysfunctional voiding
  • •Neurogenic bladder
  • •Psychiatric disorders, behavioural disturbances or mental disabilities
  • •Treated before with pharmacotherapy or invasive therapies for OAB
  • •Children with parents unable to record reliably micturition diaries.

研究组 & 干预措施

Active TTNS

Active Comparator

Children treated by transcutaneous tibial nerve stimulation. TENS device connected to adhesive electrodes. Stimulation settings: 200 µS, 20 Hz, 1-20 V ( depending of sensory response) Home-therapy: Daily stimulation during 60 minutes.

干预措施: TTNS (Device)

TTNS sham intervention

Sham Comparator

Children treated by TTNS with same positioning as the active TTNS treatment. Stimulation settings: 200 µS, 20 Hz, 0-1 V. Patients and parents will be told that electric currence is given, but that no sensation will be feld.

Home therapy: Daily stimulation during 60 minutes.

干预措施: TTNS Sham (Device)

结局指标

主要结局

Mean voided volume per void

时间窗: 12 weeks

Difference in mean voided volume per void in percentage

次要结局

  • Maximum voided volume (ml)(12 weeks)
  • Number of urgency incontinence episodes / 24 h.(12 weeks)
  • Daytime voiding frequency(12 weeks)
  • Satisfaction on urinary symptoms reported by parents(12 weeks)
  • Time to recurrence(At 12 weeks of treatment + at 6 weeks of observational period without treatment.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验